Johnson controls and phylagen sign healthy buildings joint development agreement

Cork, ireland, sept. 23, 2021 /prnewswire/ --  johnson controls (nyse: jci), the global leader for smart, healthy and sustainable buildings, today announced it has signed a joint development agreement with phylagen , a leading biotechnology company in the field of microbiome optimization of indoor environments.
JCI Ratings Summary
JCI Quant Ranking